Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-21-013320)

Filing Details

Accession Number:: 0001209191-21-013320
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-02-23 17:28:29
Reporting Period:: 2021-02-19

Accepted Time:: 2021-02-23 17:28:29
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1623526	Stoke Therapeutics Inc.	STOK	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1586226	Arthur Tzianabos	C/O Stoke Therapeutics, Inc. 45 Wiggins Avenue Bedford MA 01730		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-02-19	10,000	$2.19	10,000	No	4	M	Direct
Common Stock	Disposition	2021-02-19	10,000	$60.67	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Director Stock Option (Right to Buy)	Disposition	2021-02-19	10,000	$0.00	10,000	$2.19

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
13,447		2028-12-12	No	4	M	Direct

Footnotes

The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
The option vested as to 1/48th of the total shares on October 4, 2018 and then 1/48th of the total shares vest monthly thereafter, subject to the reporting person's continued service to the issuer through each vesting date.